KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Total Non-Current Liabilities data on record, last reported at $9.8 billion in Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 19.83% year-over-year to $9.8 billion; the TTM value through Dec 2025 reached $9.8 billion, up 19.83%, while the annual FY2025 figure was $9.8 billion, 19.83% up from the prior year.
  • Total Non-Current Liabilities reached $9.8 billion in Q4 2025 per ZBH's latest filing, down from $9.9 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $11.0 billion in Q2 2021 and bottomed at $7.6 billion in Q2 2024.
  • Average Total Non-Current Liabilities over 5 years is $9.1 billion, with a median of $8.7 billion recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: decreased 20.83% in 2022, then rose 24.94% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $10.2 billion in 2021, then decreased by 15.57% to $8.6 billion in 2022, then dropped by 6.21% to $8.1 billion in 2023, then rose by 0.77% to $8.1 billion in 2024, then grew by 19.83% to $9.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $9.8 billion in Q4 2025, $9.9 billion in Q3 2025, and $9.5 billion in Q2 2025.